Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort

The aim of the study was to analyze the real-world performance of MiniMed 780G (MM780G) Advanced Hybrid Closed Loop (AHCL) system users from Poland (PL) and compare it to the European region excluding Poland (EU-PL) in order to identify factors contributing to potential differences. The former achie...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes research and clinical practice 2024-10, Vol.216, p.111832, Article 111832
Main Authors: Matejko, Bartłomiej, van den Heuvel, Tim, Castaneda, Javier, Arrieta, Arcelia, Cyranka, Katarzyna, Cohen, Ohad, Małecki, Maciej, Klupa, Tomasz
Format: Article
Language:English
Subjects:
AHCL
Closed loop systems
RWD
RWE
Type 1 diabetes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c243t-ed948911bff7bcf44af14d180abc5697c3907f954cc1dd531c231b3701167f763
container_end_page
container_issue
container_start_page 111832
container_title Diabetes research and clinical practice
container_volume 216
creator Matejko, Bartłomiej
van den Heuvel, Tim
Castaneda, Javier
Arrieta, Arcelia
Cyranka, Katarzyna
Cohen, Ohad
Małecki, Maciej
Klupa, Tomasz
description The aim of the study was to analyze the real-world performance of MiniMed 780G (MM780G) Advanced Hybrid Closed Loop (AHCL) system users from Poland (PL) and compare it to the European region excluding Poland (EU-PL) in order to identify factors contributing to potential differences. The former achieved some of the best Time in Range (TIR) results globally using this technology. CareLink Personal data uploaded by MM780G system users from August 2020 to December 2022 were analyzed. The Polish users (N=1304) on average reached to TIR of 79.1 ± 8.7 % (vs 73.0 ± 10.0 % for EU-PL, N=55659), a TBR
doi_str_mv 10.1016/j.diabres.2024.111832
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3096279225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168822724007423</els_id><sourcerecordid>3096279225</sourcerecordid><originalsourceid>FETCH-LOGICAL-c243t-ed948911bff7bcf44af14d180abc5697c3907f954cc1dd531c231b3701167f763</originalsourceid><addsrcrecordid>eNqFkFFv0zAQxy0EYt3gI4D8yEs6n53ECS9oqsY2qRJIg2fLsc_UVRIXXzrRb790LbzydCfd7-70_zH2AcQSBNTX26WPtstISylkuQSARslXbAGNlkUjpX7NFjPXvPQX7JJoK4SoVVm9ZReqBa1q3SyYu_3jsO9xdMjjyKcN8sGO9hcOOE48BX7jn-w89Pz-0OXo-apPhL5Yp7TjjweacKDPfI1EaSQechpebnxPfaQNd2mT8vSOvQm2J3x_rlfs59fbH6v7Yv3t7mF1sy6cLNVUoG_LpgXoQtCdC2VpA5QeGmE7V9WtdqoVOrRV6Rx4XylwUkGntACoddC1umKfTnd3Of3eI01miHRMZ0dMezJKtLXUrZTVjFYn1OVElDGYXY6DzQcDwhz9mq05-zVHv-bkd977eH6x7wb0_7b-Cp2BLycA56BPEbMhF492fczoJuNT_M-LZwU7jkY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3096279225</pqid></control><display><type>article</type><title>Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Matejko, Bartłomiej ; van den Heuvel, Tim ; Castaneda, Javier ; Arrieta, Arcelia ; Cyranka, Katarzyna ; Cohen, Ohad ; Małecki, Maciej ; Klupa, Tomasz</creator><creatorcontrib>Matejko, Bartłomiej ; van den Heuvel, Tim ; Castaneda, Javier ; Arrieta, Arcelia ; Cyranka, Katarzyna ; Cohen, Ohad ; Małecki, Maciej ; Klupa, Tomasz</creatorcontrib><description>The aim of the study was to analyze the real-world performance of MiniMed 780G (MM780G) Advanced Hybrid Closed Loop (AHCL) system users from Poland (PL) and compare it to the European region excluding Poland (EU-PL) in order to identify factors contributing to potential differences. The former achieved some of the best Time in Range (TIR) results globally using this technology. CareLink Personal data uploaded by MM780G system users from August 2020 to December 2022 were analyzed. The Polish users (N=1304) on average reached to TIR of 79.1 ± 8.7 % (vs 73.0 ± 10.0 % for EU-PL, N=55659), a TBR&lt;54 mg/dL of 0.6 ± 0.7 % (vs 0.4 ± 0.6 %) and a TBR&lt;70 mg/dL of 2.9 ± 2.1 % (vs 2.1 ± 1.8 %). The adoption rate of optimal settings (i.e, GT=100 mg/dL, AIT=2hr) in PL was high (19.7 % vs 6.3 %), and filtering on optimal setting users led to less pronounced differences in glycemic control between PL and EU-PL. A univariable analysis with post-AHCL TIR showed that geography itself (PL vs EU-PL) is not a significant contributor to a high post-AHCL TIR (p = 0.15), and that much of the Polish post-AHCL TIR can be explained by the high pre-AHCL TIR. The Polish MM780G users achieved better glycemic control than the general European population (excluding Poland). This is largely attributable to the adoption of optimal settings in Poland and the already high glycemic outcomes at system start. As these characteristics can be implemented elsewhere, we believe this outstanding result can be obtained in other countries as well.</description><identifier>ISSN: 0168-8227</identifier><identifier>ISSN: 1872-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2024.111832</identifier><identifier>PMID: 39173678</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>AHCL ; Closed loop systems ; RWD ; RWE ; Type 1 diabetes</subject><ispartof>Diabetes research and clinical practice, 2024-10, Vol.216, p.111832, Article 111832</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c243t-ed948911bff7bcf44af14d180abc5697c3907f954cc1dd531c231b3701167f763</cites><orcidid>0000-0001-6938-352X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39173678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matejko, Bartłomiej</creatorcontrib><creatorcontrib>van den Heuvel, Tim</creatorcontrib><creatorcontrib>Castaneda, Javier</creatorcontrib><creatorcontrib>Arrieta, Arcelia</creatorcontrib><creatorcontrib>Cyranka, Katarzyna</creatorcontrib><creatorcontrib>Cohen, Ohad</creatorcontrib><creatorcontrib>Małecki, Maciej</creatorcontrib><creatorcontrib>Klupa, Tomasz</creatorcontrib><title>Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>The aim of the study was to analyze the real-world performance of MiniMed 780G (MM780G) Advanced Hybrid Closed Loop (AHCL) system users from Poland (PL) and compare it to the European region excluding Poland (EU-PL) in order to identify factors contributing to potential differences. The former achieved some of the best Time in Range (TIR) results globally using this technology. CareLink Personal data uploaded by MM780G system users from August 2020 to December 2022 were analyzed. The Polish users (N=1304) on average reached to TIR of 79.1 ± 8.7 % (vs 73.0 ± 10.0 % for EU-PL, N=55659), a TBR&lt;54 mg/dL of 0.6 ± 0.7 % (vs 0.4 ± 0.6 %) and a TBR&lt;70 mg/dL of 2.9 ± 2.1 % (vs 2.1 ± 1.8 %). The adoption rate of optimal settings (i.e, GT=100 mg/dL, AIT=2hr) in PL was high (19.7 % vs 6.3 %), and filtering on optimal setting users led to less pronounced differences in glycemic control between PL and EU-PL. A univariable analysis with post-AHCL TIR showed that geography itself (PL vs EU-PL) is not a significant contributor to a high post-AHCL TIR (p = 0.15), and that much of the Polish post-AHCL TIR can be explained by the high pre-AHCL TIR. The Polish MM780G users achieved better glycemic control than the general European population (excluding Poland). This is largely attributable to the adoption of optimal settings in Poland and the already high glycemic outcomes at system start. As these characteristics can be implemented elsewhere, we believe this outstanding result can be obtained in other countries as well.</description><subject>AHCL</subject><subject>Closed loop systems</subject><subject>RWD</subject><subject>RWE</subject><subject>Type 1 diabetes</subject><issn>0168-8227</issn><issn>1872-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqFkFFv0zAQxy0EYt3gI4D8yEs6n53ECS9oqsY2qRJIg2fLsc_UVRIXXzrRb790LbzydCfd7-70_zH2AcQSBNTX26WPtstISylkuQSARslXbAGNlkUjpX7NFjPXvPQX7JJoK4SoVVm9ZReqBa1q3SyYu_3jsO9xdMjjyKcN8sGO9hcOOE48BX7jn-w89Pz-0OXo-apPhL5Yp7TjjweacKDPfI1EaSQechpebnxPfaQNd2mT8vSOvQm2J3x_rlfs59fbH6v7Yv3t7mF1sy6cLNVUoG_LpgXoQtCdC2VpA5QeGmE7V9WtdqoVOrRV6Rx4XylwUkGntACoddC1umKfTnd3Of3eI01miHRMZ0dMezJKtLXUrZTVjFYn1OVElDGYXY6DzQcDwhz9mq05-zVHv-bkd977eH6x7wb0_7b-Cp2BLycA56BPEbMhF492fczoJuNT_M-LZwU7jkY</recordid><startdate>20241001</startdate><enddate>20241001</enddate><creator>Matejko, Bartłomiej</creator><creator>van den Heuvel, Tim</creator><creator>Castaneda, Javier</creator><creator>Arrieta, Arcelia</creator><creator>Cyranka, Katarzyna</creator><creator>Cohen, Ohad</creator><creator>Małecki, Maciej</creator><creator>Klupa, Tomasz</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6938-352X</orcidid></search><sort><creationdate>20241001</creationdate><title>Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort</title><author>Matejko, Bartłomiej ; van den Heuvel, Tim ; Castaneda, Javier ; Arrieta, Arcelia ; Cyranka, Katarzyna ; Cohen, Ohad ; Małecki, Maciej ; Klupa, Tomasz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c243t-ed948911bff7bcf44af14d180abc5697c3907f954cc1dd531c231b3701167f763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>AHCL</topic><topic>Closed loop systems</topic><topic>RWD</topic><topic>RWE</topic><topic>Type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matejko, Bartłomiej</creatorcontrib><creatorcontrib>van den Heuvel, Tim</creatorcontrib><creatorcontrib>Castaneda, Javier</creatorcontrib><creatorcontrib>Arrieta, Arcelia</creatorcontrib><creatorcontrib>Cyranka, Katarzyna</creatorcontrib><creatorcontrib>Cohen, Ohad</creatorcontrib><creatorcontrib>Małecki, Maciej</creatorcontrib><creatorcontrib>Klupa, Tomasz</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matejko, Bartłomiej</au><au>van den Heuvel, Tim</au><au>Castaneda, Javier</au><au>Arrieta, Arcelia</au><au>Cyranka, Katarzyna</au><au>Cohen, Ohad</au><au>Małecki, Maciej</au><au>Klupa, Tomasz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2024-10-01</date><risdate>2024</risdate><volume>216</volume><spage>111832</spage><pages>111832-</pages><artnum>111832</artnum><issn>0168-8227</issn><issn>1872-8227</issn><eissn>1872-8227</eissn><abstract>The aim of the study was to analyze the real-world performance of MiniMed 780G (MM780G) Advanced Hybrid Closed Loop (AHCL) system users from Poland (PL) and compare it to the European region excluding Poland (EU-PL) in order to identify factors contributing to potential differences. The former achieved some of the best Time in Range (TIR) results globally using this technology. CareLink Personal data uploaded by MM780G system users from August 2020 to December 2022 were analyzed. The Polish users (N=1304) on average reached to TIR of 79.1 ± 8.7 % (vs 73.0 ± 10.0 % for EU-PL, N=55659), a TBR&lt;54 mg/dL of 0.6 ± 0.7 % (vs 0.4 ± 0.6 %) and a TBR&lt;70 mg/dL of 2.9 ± 2.1 % (vs 2.1 ± 1.8 %). The adoption rate of optimal settings (i.e, GT=100 mg/dL, AIT=2hr) in PL was high (19.7 % vs 6.3 %), and filtering on optimal setting users led to less pronounced differences in glycemic control between PL and EU-PL. A univariable analysis with post-AHCL TIR showed that geography itself (PL vs EU-PL) is not a significant contributor to a high post-AHCL TIR (p = 0.15), and that much of the Polish post-AHCL TIR can be explained by the high pre-AHCL TIR. The Polish MM780G users achieved better glycemic control than the general European population (excluding Poland). This is largely attributable to the adoption of optimal settings in Poland and the already high glycemic outcomes at system start. As these characteristics can be implemented elsewhere, we believe this outstanding result can be obtained in other countries as well.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>39173678</pmid><doi>10.1016/j.diabres.2024.111832</doi><orcidid>https://orcid.org/0000-0001-6938-352X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0168-8227
ispartof Diabetes research and clinical practice, 2024-10, Vol.216, p.111832, Article 111832
issn 0168-8227
1872-8227
1872-8227
language eng
recordid cdi_proquest_miscellaneous_3096279225
source ScienceDirect Freedom Collection 2022-2024
subjects AHCL
Closed loop systems
RWD
RWE
Type 1 diabetes
title Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A24%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Excellence%20in%20the%20management%20of%20Advanced%20Hybrid%20Closed-Loop%20Systems:%20Lessons%20from%20the%20Polish%20cohort&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=Matejko,%20Bart%C5%82omiej&rft.date=2024-10-01&rft.volume=216&rft.spage=111832&rft.pages=111832-&rft.artnum=111832&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2024.111832&rft_dat=%3Cproquest_cross%3E3096279225%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c243t-ed948911bff7bcf44af14d180abc5697c3907f954cc1dd531c231b3701167f763%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3096279225&rft_id=info:pmid/39173678&rfr_iscdi=true